Skip to main content

Sinus and Headache

NDC 50804-123 · GOODSENSE

Generic nameACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE
Dosage formTABLET, COATED
RouteORAL
Active ingredient(s)ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE
Strength325; 5 mg/1; mg/1
Pharmacologic classAdrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
Marketing categoryOTC MONOGRAPH DRUG

Packages

50804-123-05 — 2 PACKAGE in 1 CARTON (50804-123-05) / 12 TABLET, COATED in 1 PACKAGE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50580-608 — acetaminophen and diphenhydramine hydrochloride, 50580-612 — Acetaminophen, 50580-614 — ACETAMINOPHEN, 50580-659 — Acetaminophen, Pseudoephedrine, 50580-692 — acetaminophen, 50580-783 — Acetaminophen, 50580-784 — Phenylephrine hydrochloride, 50580-785 — Dextromethorphan hydrobromide and Phenylephrine hydrochloride, 50580-937 — Acetaminophen, 50594-863 — Acetaminophen, Diphenhydramine HCL, 50804-128 — ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE, 50804-173 — ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, 50804-220 — ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE, 50804-256 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 50804-274 — ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, 50804-317 — Glycerin, Lidocaine, Petrolatum, Phenylephrine HCl, 50804-503 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 50804-672 — ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, 50804-805 — ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, 50804-825 — Acetaminophen and Diphenhydramine Hydrochloride, +4112 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels